- Ambrose C G, Gogola G R, Clyburn T A, Raymond A K, Peng A S, Mikos A G. Antibiotic microspheres: preliminary testing for potential treatment of osteomyelitis. Clin Orthop 2003, 415: 279–85
- Cierny G III, Mader J T, Penninck J J. A clinical staging system for adult osteomyelitis. Clin Orthop 2003, 414: 7–24
- Galanakis N, Giamarellou H, Moussas T, Dounis E. Chronic osteomyelitis caused by multi-resistant Gram-negative bacteria: evaluation of treatment with newer quinolones after prolonged follow-up. J Antimicrob Chemother 1997; 39(2)241–6
- Garvin K L, Miyano J A, Robinson D, Giger D, Novak J, Radio S. Polylactide/polyglycolide antibiotic implants in the treatment of osteomyelitis. J Bone Joint Surg (Am) 1994; 76(10)1500–6
- Giannoudis P V, Parker J, Wilcox M H. Methicillin-resistant Staphylococcus aureus in trauma and orthopaedic practice. J Bone Joint Surg (Br) 2005; 87(6)749–54
- Holtom P D, Patzakis M J. Newer methods of antimicrobial delivery for bone and joint infections. AAOS Instructional Course Lectures 2003; 52: 745–9
- Kanellakopoulou K, Kolia M, Anastassiadis A, Korakis T, Giamarellous-Bourboulis E J, Andreopoulos A, Dounis E, Giamarellou H. Lactic acid polymers as biodegradable carriers of fluoroquinolones: An in vitro study. Antimicrob Agents Chemother 1999; 43(3)714–6
- Koort J K, Mäkinen T J, Suokas E, Veiranto M, Jalava J, Knuuti J, Törmälä P, Aro H T. Efficacy of ciprofloxacin releasing bioabsorbable osteoconductive bone defect filler for treatment of experimental osteomyelitis due to Staphylococcus aureus. Antimicrob Agents Chemother 2005; 49(4)1502–8
- Koort J K, Suokas E, Veiranto M, Mäkinen T J, Jalava J, Törmälä P, Aro H T. In vitro and in vivo testing of bioabsorbable antibiotic containing bone filler for osteomyelitis treatment. J Biomed Mater Res A 2006; 78(1)532–40
- Kotilainen P, Huovinen S, Jarvinen H, Aro H, Huovinen P. Epidemiology of the colonization of inpatients and outpatients with ciprofloxacin-resistant coagulase-negative staphylococci. Clin Infect Dis 1995; 21(3)685–7
- Mader J T, Calhoun J, Cobos J. In vitro evaluation of antibiotic diffusion from antibiotic-impregnated biodegradable beads and polymethylmetacrylate beads. Antimicrob Agents Chemother 1997; 41(2)415–8
- Miclau T, Edin M L, Lester G E, Lindsey R W, Dahners L E. Effect of ciprofloxacin on the proliferation of osteoblast-like MG-63 human osteosarcoma cells in vitro. J Orthop Res 1998; 16(4)509–12
- Mäkinen T J, Veiranto M, Lankinen P, Moritz N, Jalava J, Törmälä P, Aro H T. In vitro and in vivo release of ciprofloxacin from osteoconductive bone defect filler. J Antimicrob Chemother 2005; 56(6)1063–8
- National Committee for Clinical Laboratory Standards. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically- Fifth Edition: Approved Standard M7-A5. NCCLS. Wayne, PAUSA 2000
- Nie L, Nicolau D P, Nightingale C H, Browner B D, Quintiliani R. In vitro elution of ofloxacin from a bioabsorbable polymer. Acta Orthop Scand 1995; 66(4)365–8
- Shuford J A, Steckelberg J M. Role of oral antimicrobial therapy in the management of osteomyelitis. Curr Opin Infect Dis 2003; 16(6)515–9
- Simpson A H, Deakin M, Latham J M. Chronic osteomyelitis. The effect of the extent of surgical resection on infection-free survival. J Bone Joint Surg (Br) 2001; 83(3)403–7
- Stoor P, Söderling E, Grénman R. Bioactive glass S53P4 in repair of septal perforations and its interactions with the respiratory infection-associated microorganisms Hae-mophilus influenzae and Streptococcus pneumoniae. J Biomed Mater Res 2001; 58(1)113–20
- Välimäki V V, Yrjans J J, Vuorio E I, Aro H T. Molecular biological evaluation of bioactive glass microspheres and adjunct bone morphogenetic protein 2 gene transfer in the enhancement of new bone formation. Tissue Eng 2005; 11(3-4)387–94
- Wei G, Kotoura Y, Oka M, Yamamuro T, Wada R, Hyon S-H, Ikada Y. A bioabsorbable delivery system for antibiotic treatment of osteomyelitis. J Bone Joint Surg (Br) 1991; 73(2)246–52
Acta Orthopaedica
Volume 79, 2008 - Issue 2